Brain Circulation is a publication with two principal foci: cerebrovascular perfusion and neurorehabilitation after stroke and brain injury, and cerebral collateral circulation. New and effective therapies for ischemia injury after stroke (with or without reperfusion) are of profound importance—and not only to the physicians and scientists tasked with developing and applying them, but to all suffering with such conditions in society at large, to whom advancement in these areas of inquiry will radiate. Recognizing this, it aims to present innovative work from the multidisciplinary community of basic and translational scientists, physicians, and others necessary to effectuate this advancement. Whether reviews or original experimental work, our journal will publish papers that catalyze shared discovery of the latest neuroscientific and clinical developments, with particular (but not exclusive) emphasis on the following topics: Cerebrovascular disease and treatment Thrombolysis with varying areas of concentration, including new mechanical devices for recanalization and neuroimaging/biomarkers for responsiveness to reperfusion Newly-developed concepts, techniques, and treatments in stroke reperfusion - Novel treatments in stoke, including drugs and all non-drug modalities (oxygen, hypothermia, remote pre-, per-, or post-ischemic preconditioning, and others) Neuroprotection and rehabilitation generally And while all types of analysis—experimental and technical, social and ethical, economic, statistical, and so on—are recognized as important by and covered in our journal, the journal gives priority to work with direct clinical pertinence. This is a priority that is consistent with the missions of inquiry advancement and care-optimization described above. Across the whole breadth of subjects and positions presented in its pages, however, the preeminent commitment of Brain Circulation remains as stated: to foster a multidisciplinary and innovative forum within which collaborative progress toward understanding and treating cerebrovascular pathology can thrive.
